A multicentre, multinational, double blind, randomised, parallel group, placebo-controlled study of ethyl-eicosapentaenoate (EPA) in patients with Huntington's disease (HD)
Study testing an investigational treatment in Huntington's disease.
Recruitment endedNot SpecifiedNot specifiedISRCTNTreatment trial
Recruiting in: United Kingdom
Sponsor: Laxdale Ltd (UK)
Preparing a short plain-English summary.